Graded doses of ochratoxin A incorporated into the diet (0, 0.5, 1.0, 2.0, 4.0, and 8.0 ,ug/g) of broiler chickens significantly (P < 0.05) inhibited activity of protein kinase, the initiator enzyme of the glycogen phosphorylase system, in the livers at all dose levels. Only the highest dose, 8 .0,tg/g, significantly reduced the total activity of phosphorylase kinase, which is activated by protein kinase. The total activity of phosphorylase, which is activated by phosphorylase kinase, was unaltered by ochratoxin A at any level. Addition of ochratoxin A to liver extracts from control birds inhibited protein kinase but not phosphorylase kinase. When added to extracts of livers from control birds, cyclic adenosine 3',5'-monophosphate stimulated protein kinase but not phosphorylase kinase. The cyclic adenosine 3',5'-monophosphate had no effect when added to extracts from birds fed ochratoxin A. These results suggest that ochratoxin A affects primarily the cyclic adenosine 3',5'-monophosphate-dependent protein kinase which initiates the enzymatic cascade leading to glycogenolysis. Furthermore, these results confirm an earlier assignment on morphological criteria of the glycogenosis of ochratoxicosis as a type X glycogen storage disease.
Ochratoxin A (OA), the most toxic and abundant member of a family of mycotoxins produced by several species of Aspergillus and Penicillium (3, 8, 20) , is one of the more potent mycotoxins (12) , having a lower 50% lethal dose and a lower minimal growth inhibitory dose than does aflatoxin in chickens. OA causes a multitude of toxic effects in bacteria (20) , birds (11, 12) , and mammals (19) . The diverse effects include nephrotoxicity (12, 22) , coagulopathy (4), anemia (9), leucocytopenia (2), microbial growth inhibition (7, 20) , and hepatotoxicity (12, 18, 21) . At the subcellular level, the accumulation of glycogen in the liver cells of animals with ochratoxicosis is a notable effect (7, 10, 18, 23) . The role of this hyperglycogenation in ochratoxicosis is uncertain, and the mechanisms whereby glycogen accumulates are unknown; however, it is not mobilized by glucagon as it is in a normal animal (10) . The accumulation of glycogen has been classified by morphological criteria as a type X glycogen storage disease (10; Warren and Hamilton, unpublished data). Type X disease results from a deficiency of the cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase which initiates the cascading glycogen phosphorylase system whose normal functioning results in glycogenolysis (13, 15 When the experiments were terminated after 3 weeks, the birds were killed quickly by decapitation in the manner described by Huff et al. (10) to ensure recovering the maximum quantity of tissue glycogen.
Toxin production. OA was produced by growing Aspergillus ochraceus NRRL 3174 on wheat by the static fermentation method of Trenk et al. (24) . OA was extracted from the wheat according to Steyn and Van der Merwe (22) . The toxin was purified by thicklayer preparatory chromatography on silica gel, utilizing benzene-acetic acid (9:1) as the solvent system (6). OA was removed from the silica gel by slurrying in a hot benzene-acetic acid (9:1) solution which was then filtered. The extraction procedure was repeated twice to remove all of the OA. The filtrates were then combined and evaporated. Cold benzene was added to precipitate the crude OA which was purified by recrystallizing five times from benzene.
Experimental design. (14) . The basis of this assay is that the endogenous kinase will phosphorylate, and therefore activate, added rabbit muscle phosphorylase b, the inactive form (Sigma Chemical Co.). The activated phosphorylase then is assayed as outlined above. Phosphorylase kinase in turn is activated by a cAMP-dependent protein kinase (15) . The activated, phosphorylated phosphorylase kinase form, but not the nonphosphorylated form, is active at pH 6.8, whereas at pH 8.6 both forms are active (13) . Thus, assaying for phosphorylase kinase activity at both pH values gave a measure of both protein kinase and its substrate, phosphorylase kinase. The response of phosphorylase kinase activity in liver extracts from control birds to the addition of OA (0, 0.5, 1.0, 2.0, 4.0, and 8.0 ,ug/ml) and cAMP (10 mg/ml) was determined. The effect on protein kinase activity of adding cAMP to extracts from birds fed ochratoxin was also determined.
Statistical analyses. Al data obtained in these experiments were subjected to analysis of variance in which an F ratio was calculated. If the F ratio were found to be significant (P < 0.05), the least significant difference among treatment means was calculated (1).
RESULTS
There was no significant (P < 0.05) change in the activity of glycogen phosphorylase a in the livers of chickens as a result of OA feeding b This value differs significantly (P < 0.02) from the corresponding control (no cAMP) value.
'These values differ significantly (P < 0.001) from the corresponding control (zero OA) value for this column.
activates phosphorylase kinase, was decreased significantly (P < 0.05) by even the lowest level of OA (0.5 ,ug/g). At the highest level of OA (8.0 Ag/g), the protein kinase activity was reduced by about 75%. Because protein kinase is a cAMP-dependent enzyme, it was of interest to determine the effect of exogenous cAMP on the protein kinase activity observed in extracts of livers of birds fed OA.
The addition of cAMP (Table 2 ) caused a slight but significant (P < 0.05) increase in the activity of extracts from control birds, but had no effect in extracts from birds fed OA.
The results of factorial experiments for the presence and absence of exogenous cAMP and six levels of exogenous OA on the activity of phosphorylase kinase and protein kinase in liver extracts of normal birds are given in Table 3 .
Analyses of variance revealed that neither OA nor cAMP had any significant effect on the phosphorylase kinase activity of liver extracts. On the other hand, protein kinase activity was responsive to both OA and cAMP, with OA being inhibitory and cAMP being stimulatory. In addition, there was an interaction between OA and cAMP such that cAMP stimulation disappeared in the presence of OA. DISCUSSION OA has been shown by morphological criteria to cause a type X glycogen storage disease (10; Warren and Hamilton, unpublished data). This disease has been attributed to a malfunction of the phosphorylase system of glycogenolysis (13, 16) in which glycogen is degraded by the enzyme glycogen phosphorylase after activation by phosphorylase kinase, which is in turn activated by a cAMP-dependent protein kinase. Under physiological conditions, this enzymatic cascade is triggered by the hormones, glucagon and epinephrine, which stimulate the enzyme adenyl cyclase to produce the secondary messenger cAMP (15) . The specific malfunctions in type X disease are a greatly reduced level of protein kinase and a much slighter reduction of phosphorylase kinase activity, whereas phosphorylase activity itself is unaltered (13) . The present findings during ochratoxicosis of unaltered phosphorylase (Table 1) , slightly decreased phosphorylase kinase (Fig. 1) , and greatly decreased protein kinase (Fig. 1) (Table 3) . They were also supported by the finding of cAMP stimulation of protein kinase activity when OA was omitted from the diet or from the reaction mixture and by the finding of inertness of phosphorylase kinase toward cAMP and OA (13, 15, 16) . The stimulation of protein kinase activity by cAMP in the present experiments was small, but in agreement with that observed in extracts from a human suffering type X glycogen storage disease (13) . These considerations were based on the report of OA being a noncompetitive inhibitor of the protein kinase of bacteria (7) and on speculation that OA is a noncompetitive inhibitor of the cAMP-dependent protein kinase of rat liver (18) .
The hypothesis that OA inhibits glycogenolysis by inhibiting the cAMP-dependent protein kinase in a noncompetitive fashion agrees with the observation that the glycogen accumulated during ochratoxicosis is not mobilized by gluca-APPL. ENVIRON. MICROBIOL.
on September 29, 2017 by guest http://aem.asm.org/ Downloaded from gon (10) and with the fact that glucagon results in the formation of cAMP, which normally would result in glycogenolysis (17) . In a similar fashion, a genetically determined type X disease is glucagon insensitive because protein kinase, the receptor enzyme for the secondary messenger cAMP, is missing (13, 15, 16) . While the motivation and experimental approach of the present study was to explain the effect of OA in the intact animal, it appears that further success will require a detailed analysis of the enzymes and mechanisms regulating glycogen metabolism.
